BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15051892)

  • 1. Models of granulocyte DNA structure are highly predictive of myelodysplastic syndrome.
    Malins DC; Anderson KM; Polissar NL; Ostrander GK; Knobbe ET; Green VM; Gilman NK; Spivak JL
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5008-11. PubMed ID: 15051892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA content of granulocytes, monocytes, and lymphocytes in the bone marrow smears of patients with myelodysplastic syndromes.
    Widell S; Hast R; Cox C; Auer G; Bennett JM
    Am J Hematol; 2001 Jun; 67(2):112-8. PubMed ID: 11343383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of FOS mRNA stabilization following translation arrest in granulocytes from myelodysplastic syndrome patients.
    Feng X; Shikama Y; Shichishima T; Noji H; Ikeda K; Ogawa K; Kimura H; Takeishi Y; Kimura J
    PLoS One; 2013; 8(4):e61107. PubMed ID: 23593403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients.
    Bellos F; Alpermann T; Gouberman E; Haferlach C; Schnittger S; Haferlach T; Kern W
    Cytometry B Clin Cytom; 2012 Sep; 82(5):295-304. PubMed ID: 22508616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
    Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
    Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
    Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
    Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
    Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities.
    Vercauteren SM; Sung S; Starczynowski DT; Lam WL; Bruyere H; Horsman DE; Tsang P; Leitch H; Karsan A
    Am J Clin Pathol; 2010 Jul; 134(1):119-26. PubMed ID: 20551276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell clonality in myelodysplastic syndrome].
    Krejcová H; Neuwirtová R; Cermák J; Belicková M; Brdicka R
    Sb Lek; 2002; 103(3):339-48. PubMed ID: 12688178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
    Sashida G; Ohyashiki JH; Nakajima A; Sumi M; Kawakubo K; Tauchi T; Ohyashiki K
    Clin Cancer Res; 2003 Apr; 9(4):1489-96. PubMed ID: 12684424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome.
    Kere J; Ruutu T; de la Chapelle A
    N Engl J Med; 1987 Feb; 316(9):499-503. PubMed ID: 2880296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apoptosis of peripheral leukocytes in patients with myelodysplastic syndromes].
    Hamada K; Takahashi I; Matsuoka M; Saika T; Mizobuchi N; Yorimitsu S; Takimoto H
    Rinsho Ketsueki; 1998 Nov; 39(11):1079-84. PubMed ID: 9866418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
    Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
    Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML.
    Gandini D; De Angeli C; Aguiari G; Manzati E; Lanza F; Pandolfi PP; Cuneo A; Castoldi GL; del Senno L
    Leukemia; 2002 May; 16(5):886-93. PubMed ID: 11986951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlations between membrane integrins and granulocyte defects in myelodysplastic syndromes].
    Pasotti D; Mazzone A; Fossati G; Mazzucchelli I; Pistone MC; Montagna M; Parachini N; Labbate G; Corti C; Ricevuti G
    Recenti Prog Med; 1993 Nov; 84(11):742-9. PubMed ID: 8290785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.